- Home
- HYI vs QTRX Comparison
HYI vs QTRX Comparison
Compare HYI & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYI
- QTRX
- Stock Information
- Founded
- HYI 2010
- QTRX 2007
- Country
- HYI United States
- QTRX United States
- Employees
- HYI N/A
- QTRX N/A
- Industry
- HYI Investment Managers
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- HYI Finance
- QTRX Industrials
- Exchange
- HYI Nasdaq
- QTRX Nasdaq
- Market Cap
- HYI 272.7M
- QTRX 241.2M
- IPO Year
- HYI N/A
- QTRX 2017
- Fundamental
- Price
- HYI $11.64
- QTRX $5.66
- Analyst Decision
- HYI
- QTRX Hold
- Analyst Count
- HYI 0
- QTRX 4
- Target Price
- HYI N/A
- QTRX $11.75
- AVG Volume (30 Days)
- HYI 50.6K
- QTRX 518.4K
- Earning Date
- HYI 01-01-0001
- QTRX 11-11-2025
- Dividend Yield
- HYI 9.59%
- QTRX N/A
- EPS Growth
- HYI N/A
- QTRX N/A
- EPS
- HYI N/A
- QTRX N/A
- Revenue
- HYI N/A
- QTRX $125,784,000.00
- Revenue This Year
- HYI N/A
- QTRX N/A
- Revenue Next Year
- HYI N/A
- QTRX $37.89
- P/E Ratio
- HYI N/A
- QTRX N/A
- Revenue Growth
- HYI N/A
- QTRX N/A
- 52 Week Low
- HYI $10.99
- QTRX $4.05
- 52 Week High
- HYI $12.24
- QTRX $15.67
- Technical
- Relative Strength Index (RSI)
- HYI 36.43
- QTRX 59.03
- Support Level
- HYI $11.47
- QTRX $5.01
- Resistance Level
- HYI $11.73
- QTRX $6.29
- Average True Range (ATR)
- HYI 0.10
- QTRX 0.29
- MACD
- HYI -0.03
- QTRX 0.07
- Stochastic Oscillator
- HYI 25.31
- QTRX 53.12
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.